Advancing Nanoparticle Technology Creating Opportunities for Drug Developers
While the concept of nanoparticles in drug delivery is not new, the number of research programs and active drug development projects has escalated as funding to nanotechnology developers has increased. The result is the emergence of a host of novel nanotechnologies tailored to meet the physicochemical requirements of drug developers.
Nanoparticles have already improved the availability and efficacy of some drugs, but the capabilities that evolving technologies possess will leads to a dramatic increase in the number of therapies delivered via nanoparticles. In many cases drugs in nanocrystalline form can be administered in smaller doses because they can be delivered directly to the tissue and in controlled doses related to the patient’s personal requirements.
These findings are contained in a new and comprehensive report: Nanoparticle Drug Delivery: Technologies, Targets and Therapies. The survey concludes that nanoparticle-based drug delivery will gain traction at the expense of traditional drug formulation methods, particularly among emerging biologics.
More information is available at www.greystoneassociates.org .
98 Amherst Street
Amherst, NH 03031 USA
Source: Greystone Associates
Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Advancing Nanoparticle Technology Creating Opportunities for Drug Developers here
News-ID: 46164 • Views: 643
More Releases for Amherst
Intradermal Drug Delivery Gaining Momentum as Technology and Benefits Converge
(Amherst, NH) – Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered. This trend is being fostered by the desire by patients for more user friendly methods for self-medicating, and by the need for safer, more reliable drug products that improve compliance. For drugs capable of being administered across the skin, intradermal delivery is viewed as an approach that addresses these
New Aircraft Designs Creating Opportunities for High Performance Aerospace Coati …
(Amherst, NH) – As aerospace manufacturers and their engineering teams push the design envelope to create aircraft with better fuel efficiency and lower maintenance requirements, they are relying increasingly on engineered materials for a growing list of structural and non-structural elements and components. This trend is changing the way aircraft are developed, produced and maintained. It’s also presenting opportunities for specialty materials suppliers with products that can improve production
Evolution in Markets for Radiation Curable Coatings Creating Risks and Opportuni …
(Amherst, NH) – Recent advances in materials and equipment are creating new demand for radiation curable coatings in a number of industrial applications. This new demand is occurring as several technology advances are being brought into the marketplace. By removing some of the key limitations of radcure coatings, these advances are enabling radcure coatings to meet unique application requirements, opening up a number of new opportunities. Technical advances that are having
Drug Delivery Coatings Creating Opportunities for Developers and Practitioners
(Amherst, NH) – Advances in coating technology have given rise to a new generation of coating formulations that can reliably deliver therapeutic substances from the surface of an implanted medical device. In currently approved products, these devices provide a primary function, with the drug contributing therapeutic benefit that improves patient outcomes. Currently more than two dozen companies are pursuing specialty coatings capable of delivering APIs. These participants are exploring a
Adros Energy Expands Clean Energy Business with Energy Audit Services and opens …
Adros Energy; a leading green energy company in New England, announced today that they are opening a new headquarters in Amherst, NH after a successful 1st year of operation in the renewable energy market. The company was founded in January of 2009 and has found success during the incubation period of the company. The infrastructure building of the company in 2009 includes: • Revenue generation from its solar PV,
Esensors Adds New Websensor Features
July 22, 2008 – Amherst, NY – EM01B Websensor is an environmental sensor that provides accurate measurement of temperature, relative humidity and light over a network. This month, Esensors adds some new features to EM01B Websensor. The free Websensor Data Logger now enables users to easily export the data to other software tools for analysis. This allows the flexibility to generate custom data views and make data collection more